Dravet syndrome drug trial halted early: did lorcaserin help?
Disease control
Terminated
This study tested whether lorcaserin could reduce convulsive seizures in people with Dravet syndrome, a severe form of epilepsy. It included 22 participants aged 2 and older who were already taking other seizure medications. The trial was terminated early, so results are limited.
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 17, 2026 02:03 UTC